A man over 90 years old who presents a serious case of thrombosis caused by the first dose of the AstraZeneca vaccine against COVID-19 is hospitalized in Mexico City.
According to Dr. Roberto Ovilla Martínez, head of hematology and bone marrow transplants at Hospital Ángeles Lomas, the patient Francisco Aguirre, an engineer by profession, is receiving treatment based on intravenous immunoglobulin that has helped to improve the condition.
This would be the first case of a thrombosis caused by the AstraZeneca vaccine registered in Mexico and in the entire American continent.
